March 08, 2022
Back Page
42
3
Study analyzes mainstream media coverage of the industry before and after the COVID-19 lockdown.
March 08, 2022
Features
42
3
Full-year business review of pharma and biotech sectors reveals strong momentum in advancing novel science and treatments, but likely foretells continued stock instability in near-to-medium terms.
March 08, 2022
Features
42
3
Despite disruption from the COVID-19 pandemic still in full swing, life sciences innovation activity remained undeterred, a recent report from the IQVIA Institute for Human Data Science finds—outlining the key factors driving record-breaking growth.
March 08, 2022
Features
42
3
Pharma and legal experts weigh in on the rush to secure intellectual property around psychedelic medicines, the value imperative that should govern pricing strategies, and the likely long-haul battle for more widespread decriminalization of these drugs.
March 08, 2022
Features
42
3
A look at the renewed efforts of biopharma companies in exploring age-old substances to treat mental health conditions and more, minus the negative effects.
March 08, 2022
Executive Profile
42
3
After helping lead Novo Nordisk on a transformational journey from a troubled 2016 to double-digit growth in 2021, Doug Langa, Executive Vice President, Head of North America Operations and President of Novo Nordisk, Inc., is calling on his experience of taking the less conventional and sometimes unexpected routes to success to lead Novo Nordisk into new territory.
March 08, 2022
Finance
42
3
But a doubling-down on R&D offers reason for optimism.
March 08, 2022
Marketing
42
3
Connected TV advertising now a critical component of media mix.
March 08, 2022
Technology
42
3
A new report examining pharma sector exposure makes for sobering reading, especially in US.
March 08, 2022
Leadership
42
3
For pharma teams, reaping the talent benefits requires skillful oversight.
March 08, 2022
Global Report
42
3
Efforts for a standardized approach coming to a head in Europe.
March 08, 2022
From the Editor
42
3
Prior experiences in pharma and handling of opioid epidemic offer valuable lessons.
March 08, 2022
Issue PDF
42
3
Click the title above for a link to open the Pharmaceutical Executive March 2022 issue in an interactive PDF format.
February 16, 2022
Washington Report
42
3
Pressurized political, COVID climates greet his return to top spot.